Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,527 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High pretreatment level of soluble interleukin-2 receptor is a robust prognostic factor in patients with follicular lymphoma treated with R-CHOP-like therapy.
Kusano Y, Yokoyama M, Terui Y, Inoue N, Takahashi A, Yamauchi H, Tsuyama N, Nishimura N, Mishima Y, Takeuchi K, Hatake K. Kusano Y, et al. Among authors: inoue n. Blood Cancer J. 2017 Sep 29;7(9):e614. doi: 10.1038/bcj.2017.96. Blood Cancer J. 2017. PMID: 28960192 Free PMC article. No abstract available.
Bearing 19q13 aberration predicts poor prognosis in non-germinal centre type of CD5+ DLBCL.
Mishima Y, Terui Y, Yokoyama M, Nishimura N, Ueda K, Kusano Y, Yamauchi H, Inoue N, Takahashi A, Tsuyama N, Mishima Y, Takeuchi K, Hatake K. Mishima Y, et al. Among authors: inoue n. Br J Haematol. 2018 Nov;183(4):661-664. doi: 10.1111/bjh.15001. Epub 2017 Oct 26. Br J Haematol. 2018. PMID: 29076146 Free article. Clinical Trial. No abstract available.
Impact of Omission/Reduction of Vincristine From R-CHOP in Treatment of DLBCL.
Marshall S, Nishimura N, Inoue N, Yamauchi H, Tsuyama N, Takeuchi K, Mishima Y, Yokoyama M, Ogasawara T, Mori N, Ogawa T, Sakura H, Terui Y. Marshall S, et al. Among authors: inoue n. Clin Lymphoma Myeloma Leuk. 2021 Mar;21(3):162-169. doi: 10.1016/j.clml.2020.12.017. Epub 2020 Dec 23. Clin Lymphoma Myeloma Leuk. 2021. PMID: 33483276 Free article.
Progression-free survival at 24 months as a predictor of survival outcomes after CHOP treatment in patients with peripheral T-cell lymphoma: a single-center validation study in a Japanese population.
Shirouchi Y, Yokoyama M, Fukuta T, Uryu H, Nishimura N, Mishima Y, Inoue N, Tsuyama N, Takeuchi K, Terui Y. Shirouchi Y, et al. Among authors: inoue n. Leuk Lymphoma. 2021 Aug;62(8):1869-1876. doi: 10.1080/10428194.2021.1894649. Epub 2021 Mar 10. Leuk Lymphoma. 2021. PMID: 33688781
2,527 results